SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA--test for oral cancer?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Julio P. Antelo who wrote (52)8/9/1996 10:03:00 AM
From: Mark Fleming   of 61
 
Any more news on OXYCAl?

Got this off Bloomberg's:

Bio-Dental Technologies Corp. (BDTC): Zila Inc. (ZILA) agreed to acquire the maker of dental office supplies for between
4.88 million shares to 5.36 million shares of Zila stock, valuing the transaction at between $35.4 million and $38.9 million
based on Zila's closing price of 7 1/4, down 3/8. Bio-Dental was unchanged at 5.

I wonder if the NASDAQ changes will affect the liquidity of a small stock such as ZILA. Any comments?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext